Loading…
Co-Diagnostics, Inc. is projected to rise to $10.45 by 2027, a +43% move from its current price of $7.30. CODX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $6.41 | $7.31 | $8.33 | +0.07% |
| May 30 | $6.08 | $7.31 | $8.80 | +0.14% |
| May 31 | $5.83 | $7.32 | $9.18 | +0.21% |
| Jun 1 | $5.63 | $7.32 | $9.51 | +0.28% |
| Jun 2 | $5.47 | $7.33 | $9.82 | +0.35% |
| Jun 3 | $5.32 | $7.33 | $10.10 | +0.42% |
| Jun 4 | $5.19 | $7.34 | $10.37 | +0.49% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.19 | $7.34 | $10.37 | +0.49% |
| Week 2 | $4.52 | $7.37 | $12.03 | +0.99% |
| Week 3 | $4.07 | $7.41 | $13.49 | +1.49% |
| Week 4 | $3.73 | $7.45 | $14.88 | +1.99% |
| Week 5 | $3.45 | $7.48 | $16.23 | +2.49% |
| Week 6 | $3.22 | $7.52 | $17.56 | +3.00% |
| Week 7 | $3.02 | $7.56 | $18.88 | +3.51% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Co-Diagnostics, Inc. (CODX) operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting.
The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc.
was incorporated in 2013 and is based in Salt Lake City, Utah.
Co-Diagnostics, Inc. operates within the Healthcare category and currently trades at $7.30 per share with a market cap of $26.7M. Its market rank is 4798.
A major floor 82.4% below — a decisive break under it would weaken the trend.
The nearest floor, 82.4% below — buyers have tended to step in here.
The nearest ceiling, 24.8% above — a clean break opens room to run.
A major ceiling 88.0% above — clearing it would confirm fresh momentum.
Key CODX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CODX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.52 | Buy | $5.95 | Buy |
| MA 10 | $3.54 | Buy | $4.48 | Buy |
| MA 20 | $2.65 | Buy | $3.31 | Buy |
| MA 50 | $2.12 | Buy | $2.67 | Buy |
| MA 100 | $2.58 | Buy | $3.52 | Buy |
| MA 200 | $6.62 | Buy | $6.23 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 73.46 | Sell |
| Stoch RSI (14) | 67.33 | Neutral |
| CCI (20) | 212.44 | Buy |
| Williams %R (14) | -23.13 | Info |
| MACD (12,26,9) | 0.70 | Buy |
| ROC (12) | 188.54 | Buy |
| Bollinger %B (20,2) | 1.06 | Sell |
| Stochastic %K (14) | 76.87 | Neutral |
| TRIX (15) | 3.17 | Buy |
| Awesome (5,34) | 3.32 | Buy |
| Ultimate (7,14,28) | 78.03 | Sell |
| Momentum (10) | 5.58 | Buy |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 8.06 | Sell |
| ADX (14) | 26.77 | Buy |
| ATR (14) | 0.71 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 70, SMA50 at $2.12, and SMA200 at $6.62. The 30-day range spans from $2.46 to $21.63, illustrating notable near-term volatility. Support sits at $1.28 and resistance at $9.11, forming key hurdles for near-term price action.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.28 | $7.30 | $12.33 | 0% | Neutral | |
| $7.52 | $10.45 | $15.71 | +43% | Bullish | |
| $8.44 | $12.44 | $19.89 | +70% | Bullish | |
| $6.83 | $10.60 | $17.76 | +45% | Bullish | |
| $5.75 | $9.35 | $16.30 | +28% | Bullish | |
| $6.66 | $11.32 | $20.42 | +55% | Bullish | |
| $8.12 | $14.39 | $26.75 | +97% | Bullish | |
| $9.41 | $17.37 | $33.18 | +138% | Bullish | |
| $8.87 | $17.03 | $33.34 | +133% | Bullish | |
| $8.02 | $16.01 | $32.06 | +119% | Bullish | |
| $11.55 | $25.67 | $56.46 | +252% | Bullish | |
| $20.00 | $44.45 | $102.23 | +509% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.28 | $7.30 | $8.63 | +0.00% |
| June 2026 | $5.95 | $7.14 | $8.87 | -2.17% |
| July 2026 | $6.38 | $7.78 | $9.92 | +9.00% |
| August 2026 | $6.72 | $8.31 | $10.80 | +6.77% |
| September 2026 | $6.41 | $8.01 | $10.57 | -3.66% |
| October 2026 | $6.36 | $8.02 | $10.74 | +0.23% |
| November 2026 | $6.86 | $8.74 | $11.84 | +8.90% |
| December 2026 | $7.00 | $9.00 | $12.33 | +2.96% |
Click any year to see its month-by-month CODX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CODX could reach as high as $12.33, with a base case around $7.30 and support toward $1.28 — roughly 0% from $7.30. A consolidation phase looks the most probable path here.
Expect CODX to range from $7.52 to $15.71 through 2027. The $10.45 average target implies a +43% move from current prices. That is up +43% on the projected 2026 average. Momentum favours further upside here.
The CODX price prediction for 2028 points to an average of $12.44 (low $8.44, high $19.89) — a potential gain of +70% on today's $7.30. Buyers look set to stay in control over this stretch.
In 2029, CODX is projected to trade between $6.83 and $17.76, averaging $10.60 — a potential gain of +45% from today's $7.30. That is -15% versus the projected 2028 average. Momentum favours further upside here.
Co-Diagnostics, Inc.'s 2030 outlook centres on $9.35, within a $5.75 to $16.30 range. That is -12% versus the projected 2029 average. That marks a +28% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, CODX could reach as high as $20.42, with a base case around $11.32 and support toward $6.66 — roughly +55% from $7.30. Momentum favours further upside here.
Expect CODX to range from $8.12 to $26.75 through 2032. The $14.39 average target implies a +97% move from current prices. That is up +27% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The CODX price prediction for 2033 points to an average of $17.37 (low $9.41, high $33.18) — a potential gain of +138% on today's $7.30. Momentum favours further upside here.
In 2034, CODX is projected to trade between $8.87 and $33.34, averaging $17.03 — a potential gain of +133% from today's $7.30. That is -2% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
Co-Diagnostics, Inc.'s 2035 outlook centres on $16.01, within a $8.02 to $32.06 range. That is -6% versus the projected 2034 average. That marks a +119% change versus current levels. Momentum favours further upside here.
By 2040, CODX could reach as high as $56.46, with a base case around $25.67 and support toward $11.55 — roughly +252% from $7.30. Buyers look set to stay in control over this stretch.
Expect CODX to range from $20.00 to $102.23 through 2050. The $44.45 average target implies a +509% move from current prices. That is up +73% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in CODX today (≈ 136.986301 CODX) could be worth
$6,088.53
+$5,088.53 (+509%) by 2050 · US Dollar
Based on the average projected CODX price of $44.45 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CODXwould be worth at today's price.
$1,000 invested in CODX on May 27, 2025 (≈ 133.868812 CODX) would be worth
$977.24
-$22.76 (-2.3%) today · 0.98× · US Dollar
Based on a CODX entry price of $7.47 vs. today's $7.3.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.39 | $3,054.39 | +205.4% |
| 1 month ago | $1.65 | $4,424.24 | +342.4% |
| 3 months ago | $2.32 | $3,146.55 | +214.7% |
| 6 months ago | $11.13 | $655.88 | -34.4% |
| 1 year ago | $7.47 | $977.24 | -2.3% |
| All time (5.0y) ago | $243 | $30.04 | -97.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CODX forecast.
Our base-case forecast reaches $15.00 around 2033.
Implied market cap at $15.00: $54.86M
Longer-term forecasts show a bullish trajectory beyond 2026. The 2026 average price is $7.30 with a 0% ROI and NEUTRAL sentiment, while 2027’s average is $10.45 (ROI 43.2%, BULLISH) and 2028’s average is $12.44 (ROI 70.4%, BULLISH). The path continues with 2029 at $10.60 (ROI 45.2%), 2030 at $9.35 (ROI 28.1%), 2031 at $11.32 (ROI 55.1%), 2032 at $14.39 (ROI 97.1%), 2033 at $17.37 (ROI 138%), 2034 at $17.03 (ROI 133.3%), and 2035 at $16.01 (ROI 119.3%), then accelerates to $25.67 in 2040 (ROI 251.6%) and $44.45 in 2050 (ROI 508.9%), all with BULLISH sentiment.
These figures point to a rising average price over the long run, with substantial upside potential in the 2040–2050 window. As with all forecasts, these are estimates, not guarantees, and carry inherent uncertainty.
Tap a question to reveal the answer.
Avg $9.35; min $5.75; max $16.30; ROI 28.1%; sentiment BULLISH.
Forecasts show bullish sentiment in 2027–2050 with ROIs such as 2027 43.2%, 2028 70.4%, 2032 97.1%, 2033 138%, 2040 251.6%, and 2050 508.9%, though 2026 carries ROI 0%.
Yes. The forecast max reaches $56.46 in 2040 and $102.23 in 2050, indicating potential to surpass $50 in those years.
$2.46 to $21.63.
Current price $7.30; Market cap $26.7M.
Co-Diagnostics, Inc. Community Discussion
0Share your Co-Diagnostics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.